Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients

Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients - Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044456

Enrollment

100

Registered

2021-06-09

Start date

2021-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 hospitalized patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 patients aged 20 years or older who were admitted to our hospital, (1) patients who have been diagnosed with diabetes before admission, and (2) patients who receive steroid treatment regardless of the presence or absence of diabetes.

Exclusion criteria

Exclusion criteria: 1. Patients who did not agree to participate in this study 2. Patients scheduled to undergo surgery and MRI 3. Patients using implantable medical devices such as pacemakers 4. Patients with systemic edema 5. Patients with a hyperglycemic emergency (diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome) 6. Patients using acetaminophen of 4000mg or more per day 7. Patients who have difficulty wearing the continuous glucose monitoring sensor due to skin problems 8. Pregnant patients

Design outcomes

Primary

Measure	Time frame
Profiles of sensor glucose level by intermitted-scanned continuous glucose monitoring	—

Countries

Japan

Contacts

Public ContactAkinori Hayashi

Kitasato University School of Medicine Department of Laboratory Medicine

ahayashi@kitasato-u.ac.jp042-778-8111

Outcome results